These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34969699)

  • 1. Kidney Failure Risk Equation and Cost of Care in Patients with Chronic Kidney Disease.
    Prasad B; Osman M; Jafari M; Gordon L; Tangri N; Ferguson TW; Jin S; Kappel J; Kozakewycz D
    Clin J Am Soc Nephrol; 2022 Jan; 17(1):17-26. PubMed ID: 34969699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.
    Hundemer GL; Tangri N; Sood MM; Ramsay T; Bugeja A; Brown PA; Clark EG; Biyani M; White CA; Akbari A
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1424-1432. PubMed ID: 32928746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the kidney failure risk equation in European CKD patients.
    Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Ku E; Kopple JD; McCulloch CE; Warady BA; Furth SL; Mak RH; Grimes BA; Mitsnefes M
    Am J Kidney Dis; 2018 May; 71(5):648-656. PubMed ID: 29132947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.
    Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E
    JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.
    Zhang AH; Tam P; LeBlanc D; Zhong H; Chan CT; Bargman JM; Oreopoulos DG
    Int Urol Nephrol; 2009 Dec; 41(4):977-82. PubMed ID: 19578968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.
    Bansal N; Fan D; Hsu CY; Ordonez JD; Marcus GM; Go AS
    Circulation; 2013 Feb; 127(5):569-74. PubMed ID: 23275377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study.
    Dwyer JP; Agiro A; Desai P; Cremisi H
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1057-1066. PubMed ID: 37540162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.
    Bansal N; Zelnick L; Bhat Z; Dobre M; He J; Lash J; Jaar B; Mehta R; Raj D; Rincon-Choles H; Saunders M; Schrauben S; Weir M; Wright J; Go AS;
    J Am Coll Cardiol; 2019 Jun; 73(21):2691-2700. PubMed ID: 31146814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study.
    Smekal MD; Tam-Tham H; Finlay J; Donald M; Thomas C; Weaver RG; Quinn RR; Tam K; Manns BJ; Tonelli M; Bello A; Tangri N; Hemmelgarn BR
    BMC Nephrol; 2019 Mar; 20(1):110. PubMed ID: 30922254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the kidney failure risk equation in a Portuguese cohort.
    da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
    Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.